Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tristem Trading Cyprus LtdfiledCriticalTristem Trading Cyprus Ltd
Priority to MYPI2012001348ApriorityCriticalpatent/MY157168A/en
Publication of MY157168ApublicationCriticalpatent/MY157168A/en
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
A METHOD OF TREATING VARIOUS DISEASES, DISORDERS, OR CONDITIONS IN PATIENT USING REPROGRAMMED CELLS SUCH AS RETRODIFFERENTIATED, TRANSDIFFERENTIATED, OR REDIFFERENTIATED CELLS. THE METHOD COMPRISES OBTAINING COMMITTED CELLS FROM THE PATIENT, RETRODIFFERENTIATING THE COMMITTED CELLS TO OBTAIN RETRODIFFERENTIATED TARGET CELLS, AND ADMINISTERING THE RETRODIFFERENTIATED CELLS TO THE PATIENT. IN CERTAIN EMBODIMENTS, THE METHOD COMPRISES OBTAINING COMMITTED CELLS FROM THE PATIENT, TRANSDIFFERENTIATING THE COMMITTED CELLS TO OBTAIN TRANSDIFFERENTIATED TARGET CELLS, AND ADMINISTERING THE TRANSDIFFERENTIATED TARGET CELLS TO THE PATIENT. THE RETRODIFFERENTIATED OR TRANSDIFFERENTIATED TARGET CELLS REPAIR OR REPLENISH TISSUE OR CELLS IN THE PATIENT.
MYPI2012001348A2009-10-192009-10-19Treatment using reprogrammed mature adult cells
MY157168A
(en)